2020 was a year when many things changed in the world and also Nano4Imaging. We started the year with high hopes of successfully launching EmeryGlide in the USA. However, the pandemic turned everything upside down.  Nevertheless,  we had a first live case by Dallas Children’s/UTSW during of interventional MRI at SCMR in Orlando.  We also succeeded  to keep the company financially stable and use the year of lockdown to develop and elaborate a new way forward. In a way this was possible due to the fact that many clinical teams had to interrupt their routine and had time to discuss and think about the future and new applications of interventional MRI. Many brainstorms via Teams, Zoom or other providers have created the awareness that MRI can also be used to support interventions in more complicated procedures such as angioplasty, aneurysm repair and EVAR. These discussions were fed by expertise and new relations in artificial intelligence and computer vision and his led to our new vision using marker recognition and real-time steering using passive markers

Several project applications have been elaborated to investigate the feasibility of the new approach with new clinical indications with clinical partners in Amsterdam, Nijmegen, Lausanne and Kiel-Lubeck. and new business partners.  We are happy to share that apart from a positive response from leading hospitals in Europe and the USA, also major medical technology manufacturers are supporting our new approach and vision.

Meanwhile we realize that most of us have been affected directly or indirectly by COVID-19 and we hope that you and your beloved ones have a relaxing Xmas time and a healthy, prosperous new year.